Celltrion Exports COVID-19 treatments to Pakistan

Celltrion Healthcare Plans to Ship 100,000 Vials to Pakistan

Regkirona, COVID-19 antibody treatment developed by Celltrion, will be sold overseas.

 

Celltrion Healthcare announced on the 10th that it plans to sign a contract for 100,000 vials of Regkirona with a subsidiary of Pakistan's largest order factories (POF) under the Ministry of National Defense and ship the contract.

 

"Regkirona has been approved for emergency use by certain groups before obtaining official permission from Pakistani health authorities," the company said.

 

Regkirona, which will be sold as the first batch, will be administered to confirmed COVID-19 patients among Pakistani soldiers and ordinary people.

 

100,000 vials with contracts can be administered to about 30,000 people.

 

Celltrion Healthcare plans to send medical personnel to Pakistan to provide education to local medical personnel who will be in charge of taking Regkirona.

 

Pakistan has the world's fifth largest population of 216.6 million, with an average of about 4,000 new confirmed cases of COVID-19 recently, and the cumulative number of confirmed cases has exceeded 850,000 people.

 

The cumulative death toll from COVID-19 also amounts to 18,000.

 

The situation caused by COVID-19 is getting worse, with the daily average death toll, which was maintained at 50-60 earlier this year, surpassing 150 as of the end of March.

 

"Regkirona, which will be sold this time, will help Pakistan's COVID-19 quarantine policy," Celltrion Healthcare said.

 

Regkirona has been prescribed to more than 2,700 patients since it obtained conditional approval from the MFDS in February for patients with high-risk minor and secondary diseases.

 

Recently, a total of 1,300 global clinical phase III patients have been recruited and administered in 13 countries, including Korea, the United States, Spain and Romania, and data analysis is currently underway.

 

An official from Celltrion Group said, "We are currently discussing Regkirona exports with a number of countries as well as Pakistan.

 

"Considering the limited production capacity of antibody treatments, we plan to focus our support on countries that need help from the international community."